Menu Back to DIA-Canadian-Annual-Meeting

Overview

Short Course: October 18
Meeting: October 19-20

The DIA Annual Canadian Meeting will deliver a comprehensive overview of the current biopharma and device landscape in Canada, while sharing insights into Canada’s broader role in global healthcare product development. From policy updates and priorities shared directly from Health Canada, to sessions on international work sharing and partnerships, to key regulatory, clinical, and safey considerations for drugs and devices, you will have the exclusive opportunity to address the current issues and opportunities in Canada and across the globe. This meeting presents three tracks: Regulatory, Clinical, and Pharmacovigilance (NEW). Our new pharmacovigilance track, previously its own meeting, broadens the scope of this meeting and will provide additional insights, education and knowledge sharing for our attendees to discuss and analyze the relevant challenges and opportunities for professionals working in the field in Canada.


Who should attend?

Professionals in pharmaceutical and device industries, regulatory agencies, and academia involved in:

  • Clinical Data Management/eClinical
  • Comparative Effectiveness/Health Technology Assessment
  • Clinical Safety/Pharmacovigilance
  • Clinical Research
  • Document Management/eSubmissions
  • Medical Communications
  • Outsourcing
  • Project Management
  • Public Policy/Law/Corporate Compliance
  • Quality Assurance Control
  • Regulatory Affairs
  • Research and Development
  • Statistics

Program Committee

  • Marcia  Bailey, BSN, MHS, RN
    Marcia Bailey, BSN, MHS, RN Senior Manager, Pharmacovigilance
    Sierra Oncology , Canada
  • Marilyne  Chamoun, MSc
    Marilyne Chamoun, MSc A/Manager
    Health Canada, Canada
  • Mandy  Collier
    Mandy Collier Director, Office of Planning, performance and Review Services, Therapeutic Produ
    Health Canada, Canada
  • Caroline  Croteau, PhD, RPh
    Caroline Croteau, PhD, RPh Country Safety Lead
    Pfizer Canada Inc, Canada
  • Deborah  Danoff, MD, FRCP
    Deborah Danoff, MD, FRCP Medical Evaluator
    Health Canada, Canada
  • Samar  Darwish, MBA, MSc
    Samar Darwish, MBA, MSc Director, Drug Regulatory Affairs
    Boehringer Ingelheim, Canada
  • Patrick  Fandja
    Patrick Fandja Manager, Medical Devices Section
    Health Canada, Canada
  • Fiona M Frappier, PhD
    Fiona M Frappier, PhD Manager
    Health Canada, Canada
  • Agnes  Jankowicz, MSc
    Agnes Jankowicz, MSc Executive Director, PV
    Certus PV Services Inc., Canada
  • Yatika  Kohli, PhD, MBA
    Yatika Kohli, PhD, MBA Executive Director - Global Regulatory Affairs
    NoNO Inc, Canada
  • Judith  Mergl, MSc
    Judith Mergl, MSc Director, Regulatory Affairs and Operational Services
    Abbvie, Canada
  • Kristin  Willemsen, MS
    Kristin Willemsen, MS Vice President, Scientific & Regulatory Affairs
    Food, Health & Consumer Products of Canada, Canada
Load More